NOTE 21. Subsequent Events

Gaylord Chemical Acquisition

On August 4, 2026, Holdings entered into a Stock Purchase Agreement (the "Purchase Agreement") with EagleTree-Gaylord Management Investment, L.P., a Delaware limited partnership, EagleTree-Gaylord Holdings Corp., a Delaware corporation (“Gaylord Chemical”) to acquire Gaylord Chemical, following satisfaction or waiver of certain conditions, for $850 million in cash (the "Transaction"), subject to customary adjustments. The Purchase Agreement may be terminated prior to the consummation of the Transaction by the mutual written consent of Holdings and Gaylord Chemical and in certain other circumstances. In connection with its entry into the Purchase Agreement, Holdings obtained equity financing commitments from certain investors for an aggregate of $870 million and obtained a debt financing commitment comprising a $250 million term loan and a $25 million revolving credit facility. These financing commitments will be used to finance the consideration due under the Purchase Agreement and related fees and expenses. A portion of the equity financing is expected to be provided by, and the equity financing commitments may be offset by, a proposed rights offering by the

Company (the “Rights Offering”). The record date, subscription ratio, expiration date and other terms of the Rights Offering will be described in a registration statement, including a prospectus, to be filed with the SEC. Any offer of the subscription rights or the securities issuable upon exercise of the subscription rights will be made only by means of the prospectus forming part of the registration statement, once such registration statement is declared effective.